Announcements

Announcements

Paul G. Allen Frontiers Group    [to 14 Mar 2020]
https://alleninstitute.org/what-we-do/frontiers-group/news-press/
Press Release
No new digest content identified.
 
 
BMGF – Gates Foundation  [to 14 Mar 2020]
http://www.gatesfoundation.org/Media-Center/Press-Releases
MARCH 10, 2020
Bill & Melinda Gates Foundation, Wellcome, and Mastercard Launch Initiative to Speed Development and Access to Therapies for COVID-19
COVID-19 Therapeutics Accelerator will coordinate R&D efforts and remove barriers to drug development and scale-up to address the epidemic
[See Milestones above for detail]
 
 
Bill & Melinda Gates Medical Research Institute    [to 14 Mar 2020]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.
 
 
CARB-X   [to 14 Mar 2020]
https://carb-x.org/
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
No new digest content identified.
 
 
CEPI – Coalition for Epidemic Preparedness Innovations  [to 14 Mar 2020]
http://cepi.net/
News
14 Mar 2020
$2 billion required to develop a vaccine against the COVID-19 virus
New funding will increase number vaccine candidates in development and enable crucial clinical trials

13 Mar 2020
CEPI-funded Nipah virus vaccine candidate first to reach Phase 1 clinical trial
This trial marks the first time a vaccine developed to prevent Nipah virus infection will be studied in humans.

13 Mar 2020
CEPI gets €140 million funding boost from Germany while expanding coronavirus vaccine search
CEPI also this week announced additional coronavirus vaccine development partnerships with Novavax and The University of Oxford.
10 Mar 2020
CEPI expands investment in COVID-19 vaccine development
CEPI will provide a further $4.4 million to rapidly advance 2 additional vaccine candidates against the novel coronavirus, with Novavax, Inc. and The University of Oxford.
 
 
Clinton Health Access Initiative, Inc. (CHAI)  [to 14 Mar 2020]
https://clintonhealthaccess.org/
News & Press Releases
No new digest content identified.
 
 
EDCTP    [to 14 Mar 2020]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
Latest news
No new digest content identified.
 
 
Emory Vaccine Center    [to 14 Mar 2020]
http://www.vaccines.emory.edu/
No new digest content identified.
 
 
European Medicines Agency  [to 14 Mar 2020]
http://www.ema.europa.eu/ema/
News & Press Releases
News: COVID-19: developers of medicines or vaccines to benefit from free scientific advice
Last updated: 13/03/2020
News: COVID-19: EMA meetings with delegates and experts will be held virtually until end April 2020
Last updated: 11/03/2020
News: Addressing the potential impact of novel coronavirus disease (COVID-19) on medicines supply in the EU
Last updated: 10/03/2020

 
 
European Vaccine Initiative  [to 14 Mar 2020]
http://www.euvaccine.eu/news-events
No new digest content identified.

 
FDA [to 14 Mar 2020]
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
Press Announcements
March 13, 2020 – Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization to Thermo Fisher
 
March 13, 2020 – Coronavirus (COVID-19) Update: FDA gives flexibility to New York State Department of Health, FDA issues Emergency Use Authorization diagnostic

March 11, 2020 – FDA Launches New Campaign to Help Consumers Use the New Nutrition Facts Label

March 10, 2020 – Coronavirus Disease 2019 (COVID-19) Update: Foreign Inspections

March 9, 2020 – Coronavirus Update: FDA and FTC Warn Seven Companies Selling Fraudulent Products that Claim to Treat or Prevent COVID-19

 

Fondation Merieux  [to 14 Mar 2020]
http://www.fondation-merieux.org/
News, Events
COVID-19: The Mérieux Foundation deploys diagnostic and research expertise to strengthen partner laboratories on the front line of the outbreak
March 4, 2020 – Lyon (France)
The Mérieux Foundation is working to strengthen novel coronavirus (SARS-CoV-2) detection and infection control capability among its partner laboratory networks. The Foundation’s support focuses on two interventions: strengthening diagnostic capacity by quickly deploying a molecular test to detect SARS-CoV-2, and assessing the risk of nosocomial transmission of SARS-CoV-2 in hospitals in order to better understand hospital-based prevention and infection control measures. The work is being carried out in partnership with Prof. Philippe Vanhems from Hospices Civils de Lyon and Prof. Jianwei Wang from the Christophe Mérieux Laboratory in Beijing.

 
 
Gavi [to 14 Mar 2020]
https://www.gavi.org/
Stories
13 March 2020
What is an emergency vaccine stockpile and how can they prevent pandemics?
10 March 2020
Will coronavirus herald a new era in vaccine innovation?

 
 
GHIT Fund   [to 14 Mar 2020]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that No new digest content identified.

 
 
Global Fund  [to 14 Mar 2020]
https://www.theglobalfund.org/en/news/
News & Stories
Sourcing & Management of Health Products
COVID-19 Impact on Supply Chain Logistics: Assessment and Recommendations
12 March 2020
…download in English

Sourcing & Management of Health Products
Opportunity for Evaluation of Selected Medicines
10 March 2020

 
 
Hilleman Laboratories   [to 14 Mar 2020]
http://www.hillemanlabs.org/
No new digest content identified.

 
 
Human Vaccines Project   [to 14 Mar 2020]
http://www.humanvaccinesproject.org/media/press-releases/
Press Releases
No new digest content identified.

 
 
IAVI  [to 14 Mar 2020]
https://www.iavi.org/newsroom
No new digest content identified.

 
 
International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.

 
 
International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
No new digest content identified.

 
 
IFFIm
http://www.iffim.org/
No new digest content identified.

 

IFRC   [to 14 Mar 2020]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
Global
COVID-19: IFRC, UNICEF and WHO issue guidance to protect children and support safe school operations

GENEVA/NEW YORK, 10 March 2020 – The International Federation of the Red Cross and Red Crescent Societies (IFRC), UNICEF and the World Health Organization (WHO) today issued new guidance to help protect children and schools from transmission of the COV …

Africa, Mozambique
Mozambique: Thousands remain vulnerable to recurrent disasters one year on from Cyclone Idai
Beira/Nairobi/Geneva, 11 March 2020 — It is almost 12 months since Cyclone Idai hit Mozambique, but communities remain intensely vulnerable to the next big disaster, which is a matter of “when, not if”—the International Federation of Red Cross and Red …

 
 
IVAC  [to 14 Mar 2020]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates
No new digest content identified.

 
 
IVI   [to 14 Mar 2020]
http://www.ivi.int/
Selected IVI News & Announcements
No new digest content identified.

 
 
JEE Alliance  [to 14 Mar 2020]
https://www.jeealliance.org/
Selected News and Events
No new digest content identified.

 
 
MSF/Médecins Sans Frontières  [to 14 Mar 2020]
http://www.msf.org/
Latest [Selected Announcements]
Refugees, IDPs and people on the move
Evacuation of squalid Greek camps more urgent than ever ov…
Press Release 12 Mar 2020

COVID-19 coronavirus
MSF starts COVID-19 response activities in four northern Italia…
Press Release 12 Mar 2020

Greece
Greece, the ‘shield’ of Europe, and EU leaders push migran…
Project Update 11 Mar 2020

DRC Ebola outbreaks
After the fire – how we could have better managed the DRC …
Op-Ed 11 Mar 2020

Mali
Fleeing violence in Niger, refugees in Mali remain vulnera…
Project Update 9 Mar 2020

Syria
Displaced people face a desperate situation in Idlib
Project Update 9 Mar 2020

 
 
DRC Ebola outbreaks
Crisis update – March 2020
Crisis Update 9 Mar 2020

 
 
National Vaccine Program Office – U.S. HHS  [to 14 Mar 2020]
https://www.hhs.gov/vaccines/about/index.html
NVAC 2020 Meetings
June 9-10, 2020 NVAC Meeting
September 23-24, 2020 Meeting (Virtual)

 
 
NIH  [to 14 Mar 2020]
http://www.nih.gov/news-events/news-releases

Selected News Releases

Newer anti-HIV drugs safest, most effective during pregnancy
March 11, 2020 — Dolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study of pregnant women.

Drug-delivery technology leads to sustained HIV antibody production in NIH study
March 9, 2020 — New strategy could be applied to other infectious diseases.

 
 
PATH  [to 14 Mar 2020]
https://www.path.org/media-center/
Selected Announcements
No new digest content identified.

 
 
Sabin Vaccine Institute  [to 14 Mar 2020]

http://www.sabin.org/updates/pressreleases

Statements and Press Releases

Sabin Vaccine Institute Receives $10M Grant to Raise Confidence in Vaccines

WASHINGTON, D.C – The Sabin Vaccine Institute (Sabin) today announced it has received a three-year grant valued at $10.4 million to strengthen vaccine acceptance. In 2019, the World Health Organization identified vaccine hesitancy – the reluctance or refusal to vaccinate despite the availability of vaccines – as one of the top 10 threats to global health.

Funding provided through a National Philanthropic Trust grant will launch Sabin’s new Vaccine Acceptance and Demand initiative and support several program areas: educating media and health care professionals on vaccines and immunization, supporting community-level social and behavioral research to understand vaccine acceptance and hesitancy, and enhancing understanding of social media influence on vaccination decisions.

The initiative is led by Sabin Global Immunization President Dr. Bruce Gellin who commented, “Vaccine hesitancy is creating a global health risk that must be addressed. Misinformation and disinformation about vaccines cost lives daily in communities around the world, as witnessed during the ongoing global measles resurgence. Through Sabin’s role at the intersection of immunization programs, policy and research, we will partner with local researchers, national immunization programs and other global health organizations to build evidence and provide the resources, connections and information stakeholders need to reverse this dangerous trend.”…

 
 
UNAIDS [to 14 Mar 2020]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
13 March 2020
UNAIDS—a leading organization for gender equality

11 March 2020
Mozambique: helping people living with HIV to get back on treatment

11 March 2020
Getting HIV services to marginalized groups in Papua New Guinea

9 March 2020
Adolescent girls and young women in sub-Saharan Africa more than twice as likely to acquire HIV
… In sub-Saharan Africa, gender-related factors fueling the epidemic are especially stark: adolescent girls and young women were more than twice (2.4 times) as likely to acquire HIV than their male peers.
 
 
UNICEF  [to 14 Mar 2020]
https://www.unicef.org/media/press-releases
Statement
Message from UNICEF
NEW YORK, 13 March 2020 – We have just been informed that three people working in UNICEF House in midtown east, New York have developed flu-like symptoms. They have not been confirmed positive to COVID-19. Out of an abundance of caution, we have taken the decision to close the UNICEF building and are strongly encouraging all our New York-based staff to work remotely for the next four weeks.  We are in contact with the UN medical team and the relevant local authorities. The safety and well-being of our staff and the wider New York community are first and foremost in our actions.

Press release
FACT SHEET: Handwashing with soap, critical in the fight against coronavirus, is ‘out of reach’ for billions
13/03/2020

Statement
UNICEF statement on COVID-19 outbreak
11/03/2020

Press release
UNICEF and UNFPA renew multi-country initiative to protect millions of girls from child marriage
10/03/2020
 
 
Press release

COVID-19: IFRC, UNICEF and WHO issue guidance to protect children and support safe school operations

Guidance includes practical actions and checklists for administrators, teachers, parents and children

10/03/2020
 
 
Press release
A third of youth surveyed globally by UNICEF say their education is not preparing them with the skills to get jobs
PwC and UNICEF join forces to boost youth skills worldwide
10/03/2020
 
 
Vaccination Acceptance Research Network (VARN)  [to 14 Mar 2020]
https://vaccineacceptance.org/news.html#header1-2r
Announcements
No new digest content identified.
 
 
Vaccine Confidence Project  [to 14 Mar 2020]
http://www.vaccineconfidence.org/
Latest News & Archive
No new digest content identified.
 
 
 
Vaccine Education Center – Children’s Hospital of Philadelphia  [to 14 Mar 2020]
http://www.chop.edu/centers-programs/vaccine-education-center
No new digest content identified.
 
 
Wellcome Trust  [to 14 Mar 2020]
https://wellcome.ac.uk/news
News | 9 March 2020
Wellcome pledges up to $50 million to new initiative to speed development of COVID-19 treatments
Wellcome joins the Bill & Melinda Gates Foundation and Mastercard in launching a new initiative to speed the development of and access to therapies for COVID-19. Together they are committing up to $125 million in seed funding.
 
 
The Wistar Institute   [to 14 Mar 2020]
https://www.wistar.org/news/press-releases

Press Releases

Mar. 11, 2020

Coupling Computational Protein Engineering with Synthetic DNA Technology Enhances Nanovaccine Efficacy Allowing the Patient’s Own Body to Customize Production

Synthetic DNA technology allows for in vivo assembly of complex nanovaccines able to elicit stronger immune responses in preclinical studies
 
 
WFPHA: World Federation of Public Health Associations  [to 14 Mar 2020]
https://www.wfpha.org/
Latest News
No new digest content identified.
 
 
World Organisation for Animal Health (OIE)   [to 14 Mar 2020]
https://www.oie.int/en/for-the-media/press-releases/2020/
Press Releases
No new digest content identified.

 

::::::

 
ARM [Alliance for Regenerative Medicine]  [to 14 Mar 2020]
https://alliancerm.org/press-releases/
Press Releases
ARM Announces the Cancellation of the 2020 Meeting on the Med
March 12, 2020
 
 
BIO    [to 14 Mar 2020]
https://www.bio.org/press-releases
Press Releases
No new digest content identified.
 
 
 
DCVMN – Developing Country Vaccine Manufacturers Network  [to 14 Mar 2020]
http://www.dcvmn.org/
News
No new digest content identified.
 
 
IFPMA   [to 14 Mar 2020]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
No new digest content identified.
 
 
PhRMA    [to 14 Mar 2020]
http://www.phrma.org/
Selected Press Releases, Statements
Nearly 400 cell and gene therapies in development to target a broad range of diseases
Andrew Powaleny   |     March 10, 2020
In 2017, the U.S. approved its first cell and gene therapy, making the idea of altering a gene to cure or treat a disease a reality. As the increasing pace of R&D propels cell and gene therapy forward, patients can expect more personalized treatments on the horizon. A new report released today finds that there are 362 investigational cell and gene therapies currently in clinical development – a 20% increase since 2018.

Among the cell and gene therapies in development are potential treatments for:
:: A gene therapy using adeno-associated virus (AAV)-factor VIII is designed to stimulate the production of factor VIII for the treatment of hemophilia A.
:: A gene therapy using AAV vectors is delivering a high-activity Factor IX gene to the liver for the treatment of hemophilia B.
:: A second-generation CAR-T cell therapy comprised of genetically-modified T-cells, is designed to target B-cell maturation antigen and to redirect the T-cells to recognize and kill malignant myeloma cells.
:: A gene therapy for the treatment of Stargardt disease delivers a corrected version of the ABCR gene directly in the photoreceptors in the retina.
:: A gene therapy uses a recombinant AAV9 capsid to deliver a shortened version of human dystrophin to treat Duchenne muscular dystrophy.
While there are hundreds of potential cell and gene therapies in the pipeline, a few of these innovative medicines have already been approved by the U.S. Food and Drug Administration (FDA) and are helping patients today. Currently, there are six diseases currently treated with gene or cell therapy for the treatment of cancer, eye diseases and rare hereditary diseases…